🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Takashi Ishikawa

Akita University

ORCID: 0000-0003-0247-7729

Also affiliated with National Center For Child Health and Development

Materials ScienceNeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer”.

ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer

Annals of Surgical Oncology(2025)10.1245/s10434-025-18260-2
N/A
0.241DataRank · unranked
4 citations

Kohei Chida, Rongrong Wu, Kohei Taniguchi, Amber McKenery, Brian Morreale +11 more

Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells

Scientific Reports(2024)10.1038/s41598-024-64651-y
N/A
0DataRank · unranked
5 citations

Mamoru Takada, Dhaval Ghone, Muhan Yu, Takeshi Nagashima, Hiroshi Fujimoto +9 more

VEGFA Gene Expression in Breast Cancer Is Associated With Worse Prognosis, but Better Response to Chemotherapy and Immunotherapy

World Journal of Oncology(2025)10.14740/wjon1993
N/A
0DataRank · unranked
8 citations

Kohei Chida, Rongrong Wu, Kaity Tung, Kenichi Hakamada, Takashi Ishikawa +2 more

TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer

Annals of Surgical Oncology(2025)10.1245/s10434-025-18764-x
N/A
0DataRank · unranked
1 citations

Rongrong Wu, Masayuki Nagahashi, John M.L. Ebos, Takashi Ishikawa, Masafumi Shimoda +3 more

Angiogenesis Is Associated With Aggressive Biology That Counterbalances With Tumor Immunogenicity in Hepatocellular Carcinoma

World Journal of Oncology(2025)10.14740/wjon2009
N/A
0DataRank · unranked
0 citations

Rongrong Wu, Kaity Tung, Takashi Ishikawa, Kazuaki Takabe, Raj G. Vaghjiani

ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?

Annals of Surgical Oncology(2025)10.1245/s10434-025-18377-4
N/A
0DataRank · unranked
0 citations

Kohei Chida, Rongrong Wu, Kohei Taniguchi, Amber McKenery, Brian Morreale +17 more